Brain
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
| RFA-MH-25-171 | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) | HHS-NIH11 | 02/15/2024 | 10/09/2026 |
| RFA-MH-25-170 | BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) | HHS-NIH11 | 02/15/2024 | 10/09/2026 |
| RFA-NS-24-030 | NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) | HHS-NIH11 | 02/02/2024 | 10/06/2026 |
| PAR-24-088 | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 12/13/2023 | 01/07/2027 |
| RFA-DA-24-032 | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) | HHS-NIH11 | 09/29/2023 | 08/14/2026 |
| RFA-DA-24-034 | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required) | HHS-NIH11 | 09/29/2023 | 08/14/2026 |
| RFA-DA-24-033 | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) | HHS-NIH11 | 09/29/2023 | 08/14/2026 |
| RFA-DA-24-031 | Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) | HHS-NIH11 | 09/28/2023 | 08/14/2026 |
| RFA-EY-23-001 | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) | HHS-NIH11 | 09/19/2023 | 06/15/2026 |
| PAR-23-229 | NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) | HHS-NIH11 | 08/11/2023 | 05/05/2026 |
| RFA-NS-24-014 | NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 07/21/2023 | 02/10/2025 |
| RFA-DA-25-014 | Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 07/19/2023 | 08/14/2025 |
| PAR-24-025 | Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 06/30/2023 | 09/07/2026 |
| PAR-24-024 | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/30/2023 | 09/07/2026 |
| PAR-23-168 | Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 04/17/2023 | 05/07/2026 |
| RFA-MH-23-331 | BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) | HHS-NIH11 | 04/14/2023 | 03/13/2026 |
| RFA-MH-23-330 | BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) | HHS-NIH11 | 04/14/2023 | 03/13/2026 |
| PAR-23-158 | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required) | HHS-NIH11 | 04/10/2023 | 05/07/2026 |
| PAR-23-157 | Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) | HHS-NIH11 | 04/10/2023 | 05/07/2026 |
| PAR-23-164 | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) | HHS-NIH11 | 04/07/2023 | 05/07/2026 |
| PAR-23-165 | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 04/07/2023 | 05/07/2026 |
| RFA-DC-24-001 | BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required) | HHS-NIH11 | 03/31/2023 | 09/19/2025 |
| RFA-MH-23-110 | BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | HHS-NIH11 | 03/31/2023 | 08/11/2025 |
| RFA-NS-24-004 | BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 03/14/2023 | 01/20/2026 |
| RFA-MH-22-185 | NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) | HHS-NIH11 | 07/26/2022 | 06/20/2025 |
| PAR-22-155 | Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) | HHS-NIH11 | 05/26/2022 | 06/09/2025 |
| PAR-22-137 | Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) | HHS-NIH11 | 03/15/2022 | 05/07/2025 |
| PAR-22-138 | Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) | HHS-NIH11 | 03/15/2022 | 05/07/2025 |
| PAR-22-135 | NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) | HHS-NIH11 | 03/08/2022 | 05/07/2025 |
| PAR-22-097 | Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional) | HHS-NIH11 | 02/08/2022 | 12/09/2024 |
| PAR-22-038 | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 10/12/2021 | 01/07/2025 |
| PAR-22-039 | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 10/12/2021 | 01/07/2025 |